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ABSTRACT
Purulent disease of the uterus develops in 40% of dairy cows
after parturition, when the epithelium of the endometrium is
disrupted to expose the underlying stroma to bacteria. The severity
of endometrial pathology is associated with isolation of Trueper-
ella pyogenes. In the present study, T. pyogenes alone caused
uterine disease when infused into the uterus of cattle where the
endometrial epithelium was disrupted. The bacterium secretes a
cholesterol-dependent cytolysin, pyolysin (PLO), and the plo gene
was identical and the plo gene promoter was highly similar
amongst 12 clinical isolates of T. pyogenes. Bacteria-free filtrates
of the T. pyogenes cultures caused hemolysis and endometrial
cytolysis, and PLO was the main cytolytic agent, because addition
of anti-PLO antibody prevented cytolysis. Similarly, a plo-deletion
T. pyogenes mutant did not cause hemolysis or endometrial
cytolysis. Endometrial stromal cells were notably more sensitive to
PLO-mediated cytolysis than epithelial or immune cells. Stromal
cells also contained more cholesterol than epithelial cells, and
reducing stromal cell cholesterol content using cyclodextrins
protected against PLO. Although T. pyogenes or plo-deletion T.
pyogenes stimulated accumulation of inflammatory mediators,
such as IL-1beta, IL-6, and IL-8, from endometrium, PLO did not
stimulate inflammatory responses by endometrial or hematopoi-
etic cells, or in vitro organ cultures of endometrium. The marked
sensitivity of stromal cells to PLO-mediated cytolysis provides an
explanation for how T. pyogenes acts as an opportunistic pathogen
to cause pathology of the endometrium once the protective
epithelium is lost after parturition.
bacteria, cholesterol-dependent cytolysin, cow, inflammation,
uterus
INTRODUCTION
Bos taurus dairy cattle are a major source of milk for
humans, but productivity is limited by a common endemic
disease caused by ubiquitous bacterial infection of the uterus
after parturition [1, 2]. Clinical purulent disease of the
endometrium is evident in up to 40% of dairy cows, and
subclinical disease of the endometrium affects many more
animals [1]. Reduced milk production, therapeutics, and
replacement of infertile animals cost the combined US and
European dairy industries $2 billion annually, as well as
compromising food security and animal welfare [1]. After
parturition, the single columnar epithelium lining the endome-
trium of the uterus is denuded, allowing invading bacteria
access to the underlying stromal compartment [3–5]. A wide
variety of bacteria can be found in the endometrium in the first
weeks after parturition, and commonly Escherichia coli,
Trueperella pyogenes, and Gram-positive anaerobic bacteria
are isolated from diseased animals [1, 2, 6]. These bacterial
infections lead to endometrial tissue damage, infiltration by
hematopoietic cells of the immune system, accumulation of pus
for a few to several weeks, and increased expression of
inflammatory mediators, such as interleukin (IL) -1b, IL-6, and
IL-8 [5, 7]. However, among the many bacteria found in the
endometrium, Gram-positive T. pyogenes is the bacterium most
associated with endometritis, and isolation of T. pyogenes is
correlated with histological and cytological evidence of
endometrial pathology [2, 5, 8].
T. pyogenes is commonly isolated from the mucous
membranes of ruminants, and is an opportunistic pathogen
causing mastitis, abscesses, pneumonia, and endometritis [9].
The primary virulence factor of T. pyogenes is the secreted 55-
kDa exotoxin, pyolysin (PLO), which is a member of the
cholesterol-dependent cytolysin (CDC) family of pore-forming
toxins [9]. Typically, CDCs bind cholesterol in plasma
membranes and oligomerize to form transmembrane pores
30–50 nm diameter, leading to osmotic imbalance, cell lysis,
and death [10]. Similar to a prototypical CDC, such as
streptolysin-O (SLO) from Streptococcus pyogenes, PLO also
binds and forms pore-like structures on cholesterol crystals in a
cell-free system [11]. However, PLO is the most divergent
CDC family member, and PLO is spontaneously active in vitro,
whereas other CDCs, such as SLO, require thiol activation in
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vitro [9]. Although PLO was important for causing pathology
in a mouse model of peritonitis [12], it is not clear how T.
pyogenes causes pathology in the endometrium of postpartum
cattle. Endometrial pathogenic E. coli is adapted to the bovine
endometrium [6], but it is not clear if T. pyogenes is also
adapted to cause endometrial pathology in cattle. Furthermore,
little is known about the interaction of PLO with bovine
endometrial cells or how these cells respond to PLO.
There are multiple strategies for defense against microbial
damage of tissues, including resistance, tolerance, and
immunity [13]. Recognition of microbes by mammalian cells
relies on perception of pathogen-associated molecular patterns
(PAMPs) [14]. These PAMPs are conserved microbial
molecules, such as lipopeptides, found in all bacteria, or the
cell wall lipopolysaccharide (LPS) of Gram-negative bacteria.
Recognition of PAMPs by hematopoietic cells is mediated by
binding to pattern recognition receptors, leading to the
production of cytokines, including IL-1b and IL-6, and
chemokines, such as IL-8 and other CXCL family members,
which attract and activate more hematopoietic immune cells
[14]. Although PAMPs, such as bacterial lipopeptides or LPS,
play an important synergistic role in the inflammatory response
to bacteria that secrete CDCs, it is thought that CDCs may also
bind pattern recognition receptors to induce inflammation [15,
16]. Whether PLO stimulates inflammation is not known, but
endometrial stromal and epithelial cells express pattern
recognition receptors, and these cells mount inflammatory
responses to PAMPs, such as LPS [17]. The present study
aimed to test the hypothesis that PLO is lytic for host
endometrial cells and stimulates an inflammatory response. We
found that all clinical isolates of T. pyogenes produced PLO,
and endometrial stromal cells were more sensitive to PLO-
mediated cytolysis than epithelial or immune cells, although
none of these cells generated an inflammatory response to
PLO.
MATERIALS AND METHODS
Reagents
Reagents were purchased from Sigma-Aldrich (Gillingham, UK) unless
otherwise specified below. Recombinant PLO (rPLO) [18] and anti-PLO
(aPLO) goat antiserum [18] were generous gifts from Prof. B.H. Jost
(University of Arizona).
Bacteria
The UK T. pyogenes isolates MS249, MS295, MS340, and MS348 (Farm
1), and 683C, 1362B, 50C, and 145B (Farm 2), and Portuguese isolates FMV1
and FMV7 (Farm 3), and FMV13 and FMV23 (Farm 4), were collected
previously by endometrial swab from dairy cows with persistent postpartum
endometritis, as previously described [2, 19]. Bacteria were identified by
aerobic and anaerobic culture on pre-equilibrated sheep blood agar and
MacConkey agar (Oxoid, Basingstoke, UK), and identification was based on
the characteristics of the colony, Gram stain, morphology, hemolysis,
biochemical profile (API systems; BioMe´rieux, Basingstoke, UK) and other
standard tests as described previously [2]. For experiments (see below), bacteria
were cultured at 378C in air using a bacterial growth medium comprised of
brain heart infusion (BHI) broth with 5% heat-inactivated fetal bovine serum
(FBS; Fisher Scientific, Loughborough, UK), and 0.11% v/v Tween-80. The
number of colony-forming units (cfu) was determined by plate counts on sheep
blood agar plates. To generate heat-killed T. pyogenes, aliquots of bacteria with
a known cfu/ml were incubated at 708C for 15 min and washed three times in
ice-cold PBS, followed by centrifugation at 12 000 3 g for 12 min and
resuspended in PBS, with the lack of growth confirmed by attempted culture on
sheep blood agar plates for 72 h.
A plo-inactivated T. pyogenes strain MS249 mutant (T. pyogenes Dplo) was
generated using a previously reported mutagenesis strategy for T. pyogenes
[12]. The chromosomal region encoding the plo locus was identified in the
genome sequence of T. pyogenes strain MS249, and primers were designed to
amplify a 1148-bp upstream region (PloUF and PloUR) and a 881-bp
downstream region (PloDF and PloDR) of the chromosome flanking the plo
locus, encompassing the first 144 and terminal 249 bases of the 1605-bp plo
coding region. Primers were also designed to amplify a 981-bp region
encompassing the kanamycin resistance cassette and promoter (KanRF and
KanRD) from the Epicentre Tn5 Kan-2 transposon (Epicentre, Madison, WI).
Restriction enzyme recognition sites listed in Supplemental Table S1 (all
Supplemental Data are available online at www.biolreprod.org) were
engineered into the oligonucleotide primers to facilitate cloning of the
amplification products, and PCR carried out using Phusion DNA polymerase
(NEB, Ipswich, MA) under the following program: 988C for 3 min, 35 cycles
of 988C 10 sec, 568C 1 min, 748C 30 sec, then a single cycle of 748C for 10
min. The PCR products were digested with appropriate restriction endonucle-
ases (Promega, Madison, WI) according to the manufacturer’s instructions.
Then, pBluescript SKþ (Stratagene, La Jolla, CA) was digested with SalI/
EcoRI, and the upstream similarly digested plo PCR fragment cloned in. The
resulting plasmid was then digested with EcoRI/XbaI and the downstream
similarly digested plo PCR product was cloned in. This plasmid, which houses
the upstream and downstream plo flanking regions separated by an EcoRI
restriction site, was then digested with EcoRI, and the similarly digested
kanamycin resistance cassette PCR product inserted to yield the plasmid
pBSplo_Kan in which the plo coding sequence is interrupted and replaced by
kan-2. As the plasmid pBluescript SKþ is based on a ColE replicon, and cannot
replicate within T. pyogenes, it acts as a suicide vector, which has been used
previously for mutagenesis in this organism [12]. The T. pyogenes MS249 cells
were transformed with pBSplo_Kan by electroporation, as described previously
[20]. Transformants were selected by growth on BHI agar with 10% FBS
supplemented with 30 lg/ml kanamycin and subsequently plated onto sheep
blood agar plates (Oxoid) to confirm the absence of PLO-mediated hemolysis
[12].
Bovine Cell and In Vitro Organ Cultures
Uteri and blood were collected from animals after slaughter, using animals
that were processed as part of the normal work of an abattoir. In vitro organ
cultures and isolation and culture of endometrial epithelial cells and stromal
cells were as described previously [17, 21, 22]. Briefly, bovine uteri were
collected from postpubertal, nonpregnant animals with no evidence of genital
disease or microbial infection, and the uteri were kept on ice until further
processing in the laboratory. Postpartum cattle were not used, because
experiments would be confounded by the already existent ubiquitous bacterial
contamination and inflammation of the endometrium, disruption of the
epithelium, and the presence of tissue damage [1, 3, 4]. The stage of the
reproductive cycle was determined by observation of ovarian morphology, as
described previously [23]. Genital tracts were selected for endometrial culture
from animals on Days 1–4 of estrous cycle when an ovary contained a recently
ruptured follicle (Ovarian Stage I) [23]; similar to postpartum cows, these
animals have basal peripheral plasma progesterone concentrations [2, 17].
For endometrial cell culture, endometrium from the horn ipsilateral to the
recently ruptured follicle was dissected and processed as described previously
[17, 21]. Tissue was digested in 25 ml sterile digestive solution comprised of
375 BAEE units trypsin ethylenediaminetetra-acetic acid (EDTA), 50 mg
collagenase II, 100 mg bovine serum albumin (BSA) and 10 mg DNase I in 100
ml Hanks balanced salt solution (HBSS) for 1 h at 378C with gentle agitation.
The cell suspension was filtered through a 40-lm mesh (Fisher Scientific) to
remove undigested material and the filtrate was resuspended in wash medium
comprised of 10% FBS (Biosera, Ringmer, UK) in HBSS. The suspension was
washed three times by centrifuging at 1003 g for 10 min and resuspending in
wash medium. Finally, the cells were resuspended in culture medium
comprised of RPMI-1640 medium, 10% FBS, 50 IU/ml penicillin, 50 lg/ml
streptomycin, and 2.5 lg/ml amphotericin B, and plated in 75-cm2 tissue
culture flasks (Greiner Bio-One, Stonehouse, UK). To obtain separate stromal
and epithelial cell populations, the cells were treated with Accutase until the
stroma had detached; these were then replated. Stromal and epithelial cell
populations were determined to be .99% pure as described previously [17].
The culture media were changed every 48 h until the cells reached
approximately 70% confluence, at which point they were transferred into 24-
well tissue culture plates (TPP, Trasadingen, Switzerland), or Cellview glass
chamber slides (Greiner Bio-One) for treatment. Cell cultures were maintained
at 378C, 5% CO
2
, in a humidified incubator and treatments applied within 10
days (see below). At the end of the treatment period, the culture supernatants
were harvested and stored at 208C and cell survival assessed.
Cell survival was assessed by the mitochondria-dependent reduction of 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to forma-
zan, as described previously [24]. Briefly, for the MTT assay, once the
supernatants were removed, they were replaced with fresh culture medium
containing 0.5 mg/ml MTT and incubated with the cells for 1 h; the medium
was then removed and the cells washed with Dulbecco PBS (DPBS) before
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lysis with dimethyl sulfoxide, and measurement of optical density (OD) at 570
nm using a microplate reader (POLARstar Omega; BMG Labtech, Offenburg,
Germany). The correlation between MTT OD measurements and the number of
live cells was confirmed using trypan blue exclusion and counting the number
of live cells using a hemocytometer.
For in vitro organ cultures, intact endometrium was collected from the
intercaruncular areas of the endometrium using sterile 8-mm-diameter biopsy
punches (Stiefel Laboratories Ltd, NC), and the endometrium was dissected
from the underlying tissue using sterile scissors and processed as described
previously [22]. Briefly, each sample of endometrium was immediately
transferred to HBSS supplemented with 50 IU/ml penicillin, 50 lg/ml
streptomycin, and 2.5 lg/ml amphotericin B for 5 min. The samples were
then washed twice in unsupplemented HBSS and transferred to six-well tissue
culture plates. Each well contained a single organ culture in 3 ml of culture
medium. The organ cultures were orientated with the epithelial surface
uppermost, and treatments applied (see below) for 24 h in a humidified
atmosphere with 5% CO
2
in air at 378C. The supernatants were then harvested
and frozen at208C until required for further analysis, and each organ culture
was weighed so that the production of inflammatory mediators could be
normalized to the organ weight.
Peripheral blood mononuclear cells (PBMCs) were isolated and cultured as
described previously [25]. Blood was collected from cattle within 5 min of
slaughter into tubes containing 1 mg/ml EDTA and 50 lg/ml gentamicin for 1 h
at room temperature. The blood was added to an equal volume of HBSS
containing gentamicin and amphotericin B. A total of 16 ml of the mixture was
then carefully added to 12 ml Ficoll-Paque Premium (GE Healthcare, Chalfont
St. Giles, UK) before centrifugation at 5003g, 188C, for 40 min with the brake
off. The PBMCs were harvested from the dense, white layer between the
resulting Ficoll-Paque and plasma layers. The cells were carefully transferred to
a 15-ml Falcon tube, resuspended with a Pasteur pipette, and washed twice by
adding 15 ml supplemented HBSS before being centrifuged for 15 min. The
cells were then resuspended in 5 ml RPMI and added to a 60-mm Petri dish
(Greiner Bio-One) and incubated at 378C, 5% CO
2
, for 30 min to allow the
PBMCs to adhere. The media were then removed and the dishes washed twice
with HBSS before 5 ml culture medium was added. The cells were cultured at
378C, 5% CO
2
, for 6–8 days with media changes every 48 h. When required for
treatment, the cells were transferred into 24-well tissue culture plates and
treated within 24 h of transfer.
In Vivo Bacterial Challenge Model of Endometritis
To confirm that T. pyogenes is a primary uterine pathogen, an in vivo
bacterial challenge model of bovine endometritis was used, based on a
previously described model [26]. The Kalamazoo Institutional Animal Care and
Use Committee approved the animal procedures (Animal Use Protocol number
KZ-1599e-2011-06-jes), under the Animal Welfare Act of 1966 as adminis-
tered by the Animal and Plant Health Inspection Service of the United States
Department of Agriculture. Lactating Holstein dairy cows (range, two to four
lactations), 205 days postpartum, with no uterine disease and no antibiotic
treatment within 14 days of enrolment, were randomly assigned to intrauterine
infusion of 10 ml bacterial growth medium containing 53 108 cfu of a uterine
isolate of T. pyogenes (n ¼ 5), or a no-treatment control group (n ¼ 5). The
perineum was disinfected with chlorhexidine; the endometrium scarified using
a sterile cytobrush instrument inserted through the cervix, guided by palpitation
per rectum; and the bacterial suspension infused using a sterile uterine infusion
cannula. Vaginal discharge was examined daily to evaluate uterine disease, and
uterine swabs collected on Days 0, 2, 5, 7, 9, 14, 21, and 28 after challenge for
bacterial culture, as described previously [2]. The control group was used to
determine if animals remained free of T. pyogenes and uterine disease, despite
undergoing the same invasive monitoring procedures.
Bacterial Genomic Sequences for PLO
The 12 T. pyogenes isolates from the endometrium of animals with purulent
uterine infections were examined for their DNA sequence of the plo gene and
gene promoter and compared with the previously published nucleotide
sequence for plo (GenBank accession no. U84782.2). The DNA sequences
were retrieved from genome sequences of the T. pyogenes isolates MS249,
MS295, MS340, and MS348; and by PCR for the remaining eight isolates
(GenBank accession nos. KJ150322–KJ150329) using the primers PloUF
(GTGTCGACCCTCCTGTTCAG), PloUR (GCCGAATTCAGGTCAACTT
TATC), PloDF (AAGGAATTCCGTACACCCAAG), PloDR (TCGTCTAGA
TACGCAGAATCATGAG), PloF (GTGTGCGCTCAATACGCTAT), and
PloR (TTCACAACTGTTCGCCACTG), to generate three overlapping PCR
products, which were sequenced by dideoxy chain termination/cycle sequenc-
ing on an ABI 3730XL sequencing machine (Eurofins MWG Operon,
Ebersberg, Germany), and assembled in silico to produce a sequence covering
the plo locus and flanking regions. Protein sequences for PLO present in the
National Center for Biotechnology Information database (Genbank accession
nos. AAC45754, ADU04496, BAA86937) were collected along with the
Arcanobacterium hemolyticum DSM 20595 thiol-activated cytolysin sequence
(YP_003697395) and the Streptococcus suis thiol-activated cytolysin sequence
(YP_006358469). Sequences were used in phylogeny.fr webserver to build a
phylogenetic tree as described previously [27].
Bacterial Growth Curves
To explore how different clinical isolates of T. pyogenes behave, standard
bacterial growth curves were measured for each of the 12 uterine isolates of T.
pyogenes. Briefly, 50 ml bacterial growth medium (BHI broth with 5% heat-
inactivated FBS and 0.11% v/v Tween-80) was inoculated with a starting
OD
600
of 0.002, cultured at 378C in air, and OD
600
measured by
spectrophotometer (BioQuest, South San Francisco, CA) every 2 h for 24 h
on three independent occasions for each isolate. In addition, bacteria-free
filtrates (BFF) were made by collecting each of the T. pyogenes growth
supernatants every 2 h, followed by centrifugation at 32003 g for 10 min, and
then passing the remaining supernatant through a low-binding 0.22-lm syringe
filter (Millipore, Billerica, MA).
Hemolytic Activity
CDCs cause hemolysis of red blood cells, and a standard hemolysis assay
was employed as a functional measure of cytolytic activity, using a previously
reported method [18, 28]. The hemolytic activity of BFF was measured every 2
h during the 24-h bacterial growth curve experiment for each of the 12 T.
pyogenes isolates using triplicate replicates for each isolate. The hemolysis
assay was also used to measure the potency of rPLO and SLO cytolysin
proteins. Briefly, one hemolytic unit (HU) was defined as the amount of BFF or
cytolysin releasing 50% of the hemoglobin from red blood cells after
incubation at 378C for 1 h. The BFF or cytolysin samples were serially diluted
1:2 across a round-bottomed 96-well plate (Fisher Scientific) in DPBS with 1%
v/v BSA (DPBS/BSA). The negative control was DPBS/BSA solution and the
positive control was 1% v/v Triton X-100 in DPBS/BSA. To prepare the
washed red blood cells, commercially available defibrinated horse blood
(Oxoid, Basingstoke, UK) was centrifuged at 15003 g for 10 min, 48C. The
supernatant was removed and the pelleted red blood cells were resuspended in
DPBS/BSA. The process was then repeated three to four times until the
supernatant was colorless. Subsequently, 500 ll of the red blood cell pellet was
added to 100 ml DPBS/BSA to make a 0.5% stock solution of washed red
blood cells; 100 ll washed red blood cells were added to each 100-ll sample or
control in the plate, giving a final concentration of 0.25% red blood cells. The
samples were incubated at 378C for 1 h before centrifuging at 15003 g for 5
min at room temperature to pellet intact red blood cells. Finally, 100 ll of the
resulting supernatant was transferred into a flat-bottomed 96-well plate (Fisher
Scientific) before the OD
405
of the supernatant was measured in a plate reader
(PolarStar; BMG, Ortenberg, Germany). The point at which 50% of the
hemoglobin was released from the red blood cells was calculated graphically
using the solver function of Microsoft Excel (Microsoft Corporation), setting
the positive and negative controls as the maximum and minimum limits,
respectively.
PLO in BFF
A previously reported Western blot method was used to confirm that PLO
protein was present in the BFF collected from the growth of T. pyogenes [18].
The BFF was extensively dialyzed (12- to 14-kDa cutoff membrane; Medicell,
London, UK) against PBS and concentrated 10-fold in a protein concentrator
(Eppendorf, Stevenage, UK). A total of 25 ll of BFF was then separated on a
12% polyacrylamide gel (mini-protean TGX; Bio-Rad, Hemel Hempstead,
UK), transferred to a PVDF membrane (GE Healthcare), and incubated in
blocking buffer (20 mM Tris, pH 7.6, 137 mM NaCl, 5% w/v BSA, and 0.1%
v/v Tween-20) overnight at 48C. Membranes were probed with 1:100 dilution
of aPLO goat serum [18] in blocking buffer for 2 h and washed for 5 min three
times in wash buffer (20 mM Tris, pH 7.6, 125 mM NaCl, and 0.1% v/v
Tween-20). A 1:1000 dilution of anti-goat IgG-HRP (Cell Signaling
Technology, Danvers, MA) was added for 1 h at room temperature before
the wash step was repeated. Immunoreactive bands were visualized using
Luminata Crescendo Western HRP substrate (Millipore), and images collected
using a Chemi-Doc imaging system (Bio-Rad).
Cellular Sensitivity to PLO
To explore the impact of PLO, red blood cells, endometrial epithelial cells,
and stromal cells were treated for 1 h with control culture medium or medium
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containing a range of concentrations of BFF from T. pyogenes isolate MS249
(10–500 HU as indicated in Results). Red blood cell and endometrial cell
survival was monitored by hemolysis assay and MTT assay, respectively, and
data were expressed as a percentage of the control. The experiment was
repeated on three independent occasions. To evaluate the cellular sensitivity to
each of the 12 clinical isolates, the BFF of each isolate was diluted to 150 HU
in culture medium before treating endometrial epithelial and stromal cells for 1
h; cell survival was monitored by MTT assay, and data were expressed as a
percentage of the control. The experiment was repeated on three independent
occasions.
To test if cytolysis by BFF was specifically caused by native PLO in BFF,
red blood cells and endometrial stromal cells were treated with 150 HU BFF for
1 h with a blocking antibody for PLO (aPLO) [18]; cell survival was monitored
by hemolysis assay and MTT assay, respectively, and data were expressed as a
percentage of the control. The experiment was repeated on three independent
occasions.
To specifically explore the impact of PLO, endometrial stromal and
epithelial cells were treated for 24 h with control culture medium or medium
containing rPLO [18] using a range of concentrations (0.3–30 HU, as specified
in Results); cell survival was monitored by MTT assay, and data were
expressed as a percentage of the control. The experiment was repeated on four
independent occasions. To verify the changes in MTT OD observed for stromal
cells, these cells were also cultured on glass chamber slides (CELLview,
Greiner Bio-One) and treated with 3 or 30 HU rPLO for 24 h before staining
with Hoechst 33342 to visualize cell nuclei using an epifluorescent microscope
(Axio Imager.M1; Zeiss, Jena, Germany). The experiment was repeated on
three independent occasions.
To evaluate the impact of native PLO secreted by T. pyogenes, endometrial
cells were treated with control culture medium or medium containing live T.
pyogenes (strain MS249) or the same strain of T. pyogenes that lacked
functional plo (T. pyogenes Dplo). Cells were treated for 24 h with control
culture medium or medium containing a range of multiplicities of infection
(MOIs) of MS249 (0.01 to 100 MOI, as indicated in Results) or 100 MOI T.
pyogenes Dplo. In independent experiments, red blood cells or endometrial
epithelial and stromal cells were treated with control culture medium or
medium containing 1, 10, or 100 MOI T. pyogenes Dplo. Cell survival was
monitored by hemolysis assay or MTT assay, respectively, and data were
expressed as a percentage of the control. The experiments were repeated on
four independent occasions.
To test if endometrial cell sensitivity was generalized for other members of
the CDC family, endometrial cells were treated for 24 h with control culture
medium or medium containing 0.003–30 HU of rPLO, or 0.003–30 HU 10 mM
DL-Dithiothreitol (DTT)-activated SLO from S. pyogenes, which is not a
pathogen of the bovine uterus [2]. In addition, cells were also treated with 10
mM DTT to evaluate DTT toxicity, and with 1 lg/ml ultrapure LPS from E.
coli O111:B4 (Invivogen, Toulouse, France) to examine whether the
prototypical PAMP might impact cell survival. Cell survival was monitored
by MTT assay, and data were expressed as a percentage of the control. The
experiment was repeated on four independent occasions.
Hematopoietic immune cells are important in endometrial pathology, and so
neutrophils, monocytes, and lymphocytes were examined for sensitivity to
rPLO. Briefly, 40-ml samples of venous blood were collected into heparin-
containing tubes (BD, Heidelberg, Germany) from three Holstein cows, and the
cells labeled with R-phycoerythrin-conjugated anti-CD14 monoclonal antibody
(AbD Serotec, Oxford, UK) for 30 min at 48C in PBS containing 0.5% BSA
and 0.01% sodium fluoride. After washing twice in PBS, 3 3 105 cells were
seeded in round-bottomed, 96-well plates and incubated in control culture
medium or medium containing 0.003–100 HU/well PLO (as specified in
Results) for 1 h at 378C, with 5% CO
2
in air. The number of viable neutrophils,
monocytes, and lymphocytes were quantified by flow cytometry using an
Accuri cytometer (BD) and at least 30 000 events, as described previously [29].
The Kinetics of Cellular Sensitivity to PLO
The kinetics of PLO activity were explored using fluorescent-labeled
phalloidin, which is normally excluded from cells with an intact plasma
membrane, but can gain entry to the cytosol through CDC pores, where
phalloidin binds to F-actin and fluoresces as described previously [30]. Briefly,
endometrial stromal and epithelial cells were seeded in four-chamber CELL-
view chamber slides. After 16 h, Hoechst 33342 (Invitrogen, Paisley, UK)
diluted 1:1000 in culture medium was added, and images collected before
addition of 30 HU rPLO along with Alexa Fluor 555 phalloidin (Invitrogen) to
give a final dilution of 1:100. Samples of three independent experiments were
analyzed on an LSM710 confocal microscope (Zeiss), using the diode (405 nm
excitation) and helium-neon (543 nm) lasers, and a 203 C-apochromat
objective. Images were collected and cellular florescence intensity measured by
confocal microscopy every 3 min, using the Zen 2009 software (Zeiss).
Cellular Cholesterol and Sensitivity to PLO
PLO is a member of the family of CDCs, which bind cholesterol-rich areas
of the plasma membrane of cells to form pores, and can bind and form pore-like
structures on cholesterol crystals in a cell-free system [9, 11]. As cholesterol is
essential for the action of CDCs, bovine endometrial epithelial and stromal cell
cholesterol content was measured on three independent occasions using the
Amplex Red Cholesterol Assay Kit (Invitrogen), according to the manufac-
turer’s instructions.
Cyclodextrins were used to further explore the role of cellular cholesterol,
because they deplete cholesterol from plasma membranes [31]. Cyclodextrins,
and particularly methyl-b-cyclodextrin, bind and sequester cholesterol
molecules, and the consequent removal of cholesterol from cell membranes
can reduce the hemolytic activity of CDCs [10, 31]. To evaluate the impact of
cyclodextrins on stromal cell cholesterol content, endometrial stromal cells
were treated for 0 and 24 h with 1000 lM a-cyclodextrin, methyl-b-
cyclodextrin, or c-cyclodextrin before measuring cellular cholesterol
concentration, on three independent occasions. To evaluate if depletion of
cellular cholesterol protected stromal cells against PLO-mediated cytolysis,
cells were treated with control culture medium or medium containing a range
of concentrations for each of a-cyclodextrin, methyl-b-cyclodextrin, or c-
cyclodextrin (1, 10, 100, and 1000 lM) for 24 h before treatment with control
culture medium or medium containing 15 HU rPLO for 24 h; cell survival
was monitored by MTT assay, and data were expressed as a percentage of the
control. The experiment was repeated on four independent occasions for each
cyclodextrin.
Cellular Responses to T. pyogenes
As endometrial pathology involves inflammation as well as tissue damage,
the cellular inflammatory responses to T. pyogenes and PLO were explored
using in vitro organ cultures, endometrial cells, and hematopoietic immune
cells. In vitro organ cultures were treated for 24 h with control culture medium,
or medium containing live T. pyogenes (strain MS249; 103–107 cfu/ml), the
same strain of T. pyogenes that lacked functional plo (T. pyogenes Dplo; 103–
107 cfu/ml), or rPLO (0.003–30 HU), or the prototypical PAMP LPS as a
positive control using 1 lg/ml ultrapure LPS, as described previously [17, 32].
Experiments were repeated on four independent occasions, with treatments
applied to duplicate replicate wells in 24-well cell culture plates. Supernatants
were collected and stored at208C until being used for ELISA to measure IL-
1b, IL-6, and IL-8.
Endometrial epithelial and stromal cells were treated for 24 h with control
culture medium, medium containing heat-killed T. pyogenes MS249 (equiv-
alent of 0.1–1000 MOI, as specified in Results), or rPLO (0.003–30 HU, as
specified in Results), or 1 lg/ml ultrapure LPS as a positive control. To
examine if cellular responses to PLO were indicative of other CDCs, stromal
cells were also treated with 0.003–30 HU SLO activated using 10 mM DTT, or
1 lg/ml ultrapure LPS as a positive control PAMP. Experiments were repeated
on four independent occasions, with treatments applied to duplicate replicate
wells in 24-well plates. Supernatants were collected and stored at208C until
being used for ELISA to measure IL-1b, IL-6, IL-8, CXCL1, CXCL2, and
CXCL3.
To examine if hematopoietic cells generate inflammatory responses to PLO,
PBMCs were treated for 24 h with control culture medium or medium
containing rPLO (0.003–3 HU, as specified in Results), or 1 lg/ml ultrapure
LPS as a positive control. Experiments were repeated on four independent
occasions, with treatments applied to duplicate replicate wells in 24-well plates.
In addition, PBMC survival was monitored by MTT assay, and data were
expressed as a percentage of the control.
ELISA
Concentrations of IL-1b, IL-6, and IL-8 were measured in culture
supernatants by ELISA according to the manufacturers’ instructions (Bovine
IL-1b Screening Set ESS0027 and Bovine IL-6 Screening Set ESS0029
[Thermo Fisher Scientific]; Human CXCL8/IL-8 DuoSet DY208 [R&D
Systems, Abingdon, UK]). The Human CXCL8/IL-8 DuoSet was previously
validated for measurement of bovine IL-8 [33]. The limits of detection for IL-
1b, IL-6, and IL-8 were 20.1, 35.6, and 14.3 pg/ml, respectively; the intra-assay
coefficients of variance were 4.6%, 1.2%, and 1.7%, respectively, and the
interassay coefficients of variance were 7.7%, 3.0%, and 5.5%, respectively.
Concentrations of CXCL1, CXCL2, and CXCL3 were measured by ELISA, as
described previously [34]; the limits of detection were ,60, 300, and 400 pg/
ml, respectively, and inter- and intra-assay coefficients of variation were all
,8% and ,5%, respectively [34]. Data are reported as pg/mg of tissue for
organ culture, and pg/ml for cell culture experiments.
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Statistical Analysis
Data are presented as arithmetic mean (SEM). Statistical analyses used t-
test, or ANOVA with Bonferroni or Dunnett pairwise multiple comparison t-
test (SPSS ver. 16; SPSS Inc., Chicago, IL) to compare means. Comparison of
proportions was tested by Chi-square test, and correlations were examined
using Pearson or Kappa tests. Significance was ascribed at P , 0.05.
RESULTS
T. pyogenes as a Primary Pathogen
To establish whether T. pyogenes acted as a primary uterine
pathogen, an in vivo bacterial challenge model of bovine
endometritis was used, based on a previously described model
[26]. Holstein cows with no history of uterine disease were
randomly assigned to intrauterine infusion of T. pyogenes or
untreated control. Mucopurulent uterine discharge was evident
in four out of five infused animals and one out of five control
animal, and T. pyogenes was consistently isolated from animals
infused with bacteria (five out of five), but not control animals
(zero out of five). Mucopurulent discharge was associated with
isolation of T. pyogenes on Days 4 and 6 after challenge
(Kappa 0.35 and 0.36, respectively; P , 0.05), and discharge
persisted for 18 6 2 days in infused animals.
T. pyogenes Expression of PLO
The plo gene and plo gene promoter was sequenced for 12
T. pyogenes isolates from the endometrium of animals with
purulent uterine infections; eight isolates were from two UK
farms [2], and four isolates were from two Portuguese farms
[19]. The plo gene was identical among the 12 isolates
(Supplemental Fig. S1). Furthermore, the plo gene of the 12
isolates was identical to a previously published sequence
(GenBank accession no. U84782.2). The nucleotide sequence
of the plo promoter was also highly conserved, with only minor
variations among the 12 strains of T. pyogenes (Supplemental
Fig. S2). The 12 isolates also had highly similar bacterial
growth characteristics (Supplemental Fig. S3A). The bacterium
is hemolytic, and the kinetics of hemolytic activity was similar
across the growth curve for the 12 isolates, with maximal
hemolytic activity in early stationary phase of growth
(Supplemental Fig. S3B). The BFF from cultures of each of
the 12 bacterial isolates caused hemolysis, as determined using
the standard hemolysis assay (Supplemental Fig. S3C), and
PLO protein was identified in BFF by Western blot
(Supplemental Fig. S3D).
To test if PLO in BFF was functional, BFF from T.
pyogenes isolate MS249 (10–500 HU) was added to red blood
cells or endometrial stromal and epithelial cells for 1 h, before
assessment of cell survival by hemolysis or MTT assays,
respectively. The MTT assay does not rely on dye exclusion or
plasma membrane integrity, and has been used previously to
measure cell viability in response to CDCs [35]. There was also
a linear relationship between MTT OD and the number of
viable endometrial cells (r2 ¼ 0.99, P , 0.001, Pearson
correlation). The lowest concentration of BFF, equivalent to 10
HU in the hemolysis assay, caused complete lysis of red blood
cells (Fig. 1A). Stromal cell lysis was evident with 50 HU of
BFF, and few cells survived 250 HU of BFF, whereas
epithelial cell survival was only significantly reduced by 500
HU BFF (Fig. 1A). The BFF from each T. pyogenes isolate,
adjusted to 150 HU, also caused more stromal than epithelial
cytolysis (26 6 3% vs. 83 6 9% survival compared with
control culture medium, P , 0.05, ANOVA), with no
significant difference in potency among isolates (Fig. 1B). To
test if cytolysis was specifically caused by native PLO in BFF,
red blood cells and stromal cells were treated with 150 HU
BFF for 1 h with a blocking antibody for PLO (aPLO) [18],
and this approach prevented both hemolysis and endometrial
stromal cytolysis (Fig. 1C).
Differential Cell Sensitivity to PLO
To explore the impact of PLO, endometrial cells were
treated for 24 h with rPLO [18]. Fewer stromal than epithelial
cells survived treatment with .20 HU rPLO (19.8 6 1.7 vs.
FIG. 1. Cytolytic activity of T. pyogenes BFF. A) Cytolysis of red blood
cells and bovine endometrial stromal and epithelial cells treated for 1 h
with the indicated concentrations of BFF, as determined by hemolysis
assay for red blood cells, and MTT assay for endometrial cells. Data are
expressed as a percent of control, and values differ from control by
ANOVA and Dunnett pairwise t-test; *P, 0.05. B) Survival of endometrial
stromal and epithelial cells treated for 1 h with 150 HU BFF from each of
12 T. pyogenes isolates. Data are expressed as a percent of control, and
differences between cell type were evaluated by independent t-test; *P ,
0.05. C) Survival of red blood cells and stromal cells when treated with
control culture medium or medium containing 150 HU BFF T. pyogenes,
with or without anti-PLO antibody (aPLO) for 1 h. Data are expressed as a
percent of control, and values differ where indicated, as determined by
ANOVA and Bonferroni post hoc test; *P , 0.05. Data are presented as
mean (SEM) of cells from 3 animals for each experiment.
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40.0 6 5.0% survival, P , 0.001, ANOVA), although sublytic
concentrations of ,10 HU rPLO increased the number of
stromal cells compared with control (Fig. 2A). To verify the
changes in MTT OD, stromal cells were cultured on glass
chamber slides and treated with 3 or 30 HU rPLO for 24 h
before staining with Hoechst 33342 to visualize cell nuclei.
There were more Hoechst 33342-positive nuclei when stromal
cells were treated with 3 HU rPLO than control culture medium
(219 6 35 vs. 128 6 15 cells/mm2, P , 0.05, t-test), whereas
few stromal cells survived treatment with 30 HU rPLO (5 6 1
vs. 128 6 15 cells/mm2, P , 0.05, t-test).
To evaluate the impact of native PLO, endometrial cells
were treated with a range of MOIs of live T. pyogenes strain
MS249. An MOI of 100 T. pyogenes reduced stromal and
epithelial cell survival after 24 h (Fig. 2B). However, there was
no detectable cytolysis when stromal cells were treated with
100 MOI of the same strain of T. pyogenes that lacked
functional plo (T. pyogenes Dplo; Fig. 2B). Furthermore, the
BFF from T. pyogenes Dplo bacteria did not cause hemolysis
(HU ¼ 0). An increase in the number of stromal, but not
epithelial, cells was evident following treatment with ,10 MOI
live T. pyogenes (Fig. 2B). However, 1, 10, or 100 MOI T.
pyogenes Dplo did not significantly impact the number of
stromal or epithelial cells (Supplemental Fig. S4, A and B).
To test if differential endometrial cell sensitivity was
generalized for other members of the CDC family, endometrial
cells were treated with SLO from S. pyogenes, which is not a
pathogen of the bovine uterus [2]. Following DTT activation,
which is necessary for most CDCs apart from PLO, 30 HU
SLO caused 100% stromal cytolysis after 24 h, although 3 HU
did not significantly affect cell survival (Fig. 3A). This is in
contrast to 3 HU rPLO within the same experiment, which
reduced stromal cell survival by 53.9 6 8.9% of control (Fig.
3B). Data for epithelial cells were not obtained, because DTT
was toxic and DTT alone caused rapid epithelial, but not
stromal, cell death.
Hematopoietic immune cells are also important in endome-
trial pathology, and so neutrophils, monocytes, and lympho-
cytes were treated with a range of concentrations of rPLO for 1
FIG. 2. Cytolytic activity of PLO and T. pyogenes. Percentage survival of stromal and epithelial cells after 24-h treatment with the indicted
concentrations of rPLO (A) or the indicated MOI of live T. pyogenes (B), or 100 MOI of the same strain that lacked functional plo (Dplo). Data are
expressed as a percent of control, and are presented as mean (SEM) of four independent experiments. Values differ from control by ANOVA and Dunnett
pairwise t-test; *P , 0.05.
FIG. 3. Stromal cell survival after treatment with CDCs. Stromal cells
were treated with 0.003–30 HU of SLO (A) or rPLO (B) for 24 h, and 1 lg/
ml LPS as a positive control. Cell survival was assessed by MTT assay. Data
are presented as mean (SEM) of four independent experiments.
Differences from control were assessed by ANOVA and Dunnett two-
sided comparison; *P , 0.05. ND, values below the limits of detection.
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h to examine cytolysis. Addition of 100 HU rPLO reduced
neutrophil, monocyte, and lymphocyte survival to 44.7 6
6.0%, 52.1 6 8.6%, and 11.2 6 1.8% of cells in control
media, respectively (Fig. 4). However, 3 HU rPLO did not
significantly affect neutrophil, monocyte, or lymphocyte
survival.
The Kinetics of PLO Action
The kinetics of PLO activity were explored using
fluorescent-labeled phalloidin, which is normally excluded
from cells with an intact plasma membrane, but can gain entry
to the cytosol through CDC pores, where phalloidin binds to F-
actin and fluoresces [30]. Endometrial stromal and epithelial
cells were concurrently treated with rPLO and fluorescent-
labeled phalloidin, and fluorescence monitored by confocal
microscopy. After 2 h, 57 6 1% of stromal cells and, after 4 h,
94 6 4% of stromal cells had phalloidin ingress (Fig. 5A),
whereas fewer epithelial cells were fluorescent even after 4 h
(15 6 1%, P , 0.001, Chi-square test; Fig. 5B). In addition,
the fluorescence intensity associated with phalloidin ingress
was higher for stromal than epithelial cells (128 6 4 arbitrary
units/cell [n¼ 164] vs. 81 6 5 arbitrary units/cell [n¼56], P,
0.001, t- test). The rate of increase in fluorescence intensity was
more rapid for cells treated with rPLO than in control culture
medium (Fig. 5, C and D; P , 0.001, ANOVA), and more
rapid for stromal than epithelial cells treated with rPLO (P ,
0.001, ANOVA).
Cellular Cholesterol and Sensitivity to PLO
PLO is a CDC, and binds and forms pore-like structures on
cholesterol crystals in a cell-free system [9, 11], so endometrial
cell cholesterol content may influence the cellular sensitivity to
PLO. Indeed, stromal cells contained more cholesterol than
epithelial cells (Fig. 6A). As such, we considered if reducing
stromal cell cholesterol might protect against the cytolytic
activity of PLO. Concentrations of stromal cell cholesterol
were reduced by 24-h treatment with 1000 lM methyl-b-
cyclodextrin, but not following treatment with a-cyclodextrin
or c-cyclodextrin (Fig. 6B). Treatment of stromal cells with
methyl-b-cyclodextrin afforded a concentration-dependent
protection against 15 HU rPLO, with 1000 lM methyl-b-
cyclodextrin abrogating cytolysis; stromal cytolysis was also
reduced by 1000 lM c-cyclodextrin, but not a-cyclodextrin
(Fig. 6C).
Cellular Responses to T. pyogenes
The cellular responses to T. pyogenes and PLO were
explored because endometrial pathology associated with
isolation of T. pyogenes involves inflammation as well as
endometrial tissue damage [5, 8]. Supernatants of in vitro organ
cultures of endometrium accumulated IL-1b, IL-6, and IL-8
following 24-h treatment with 103–107 cfu live T. pyogenes
strain MS249 (Fig. 7A) or T. pyogenes Dplo (Fig. 7B), and the
responses were of similar magnitude to the 1 lg/ml LPS
positive control; the T. pyogenes cfu after treatment did not
differ significantly from the input cfu following 24-h culture in
culture medium. However, there was no detectable accumula-
tion of IL-1b, IL-6, or IL-8 after 24 h treatment of in vitro
organ cultures of endometrium with 0.003–30 HU rPLO (Fig.
7C).
Endometrial stromal and epithelial cell supernatants also
accumulated more IL-6 after 24-h treatment with heat-killed T.
pyogenes equivalent to 1000 MOI compared with control
culture medium (Fig. 8A). However, stromal or epithelial cell
supernatants did not accumulate detectable amounts of IL-6 or
IL-8 after 24-h treatment with 0.003–30 HU rPLO (Fig. 8B).
The concentrations of IL-1b were below the limits of detection
of the assay. Similarly, the concentrations of CXCL1, CXCL2,
and CXCL3 were below the limits of detection of the assays for
stromal or epithelial cells treated with rPLO; although the cells
responded to 1 lg/ml LPS (stroma, 761.3 6 92.3, 2693.3 6
386.5, and 1588.3 6 184.3 pg/ml, respectively; epithelium,
2283.6 6 164.2, 2254.0 6 474.4, and 3334.0 6 250.3 pg/ml,
respectively; P , 0.05, ANOVA).
The absence of an inflammatory response to PLO, indicative
of innate immunity, was not limited to this particular CDC,
because concentrations of IL-1b, IL-6, or IL-8 were all below
the ELISA limits of detection for stromal cells treated with
0.003–30 HU SLO.
To examine if hematopoietic cells might generate inflam-
matory responses to PLO, PBMCs were treated with 0.003–3
HU rPLO for 24 h. However, while there were the expected
cellular responses to LPS with increased accumulation of IL-
1b, IL-6, and IL-8, there was no detectable accumulation of IL-
FIG. 4. Hematopoietic immune cell survival after treatment with PLO.
Neutrophils, monocytes, and lymphocytes were isolated from bovine
blood and treated with 0.003–100 HU rPLO for 1 h before FACS analysis
of cell survival. Data are presented as mean (SEM) of three independent
experiments. Values differ significantly by ANOVA and Dunnett two-sided
post hoc comparison with control (0); *P , 0.05.
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1b, IL-6, or IL-8 in the supernatant of cells treated with rPLO
(Supplemental Fig. S5A), and only the highest concentration of
rPLO reduced PBMC survival (64.0 6 3.4 % of control, P ,
0.05, ANOVA; Supplemental Fig. S5B).
DISCUSSION
The present study explored the mechanisms of how T.
pyogenes causes tissue damage in the endometrium after
parturition. The plo gene was conserved and the gene promoter
was similar among multiple clinical isolates of T. pyogenes.
The BFF from each bacterial isolate caused hemolysis and
cytolysis of endometrial stromal and epithelial cells. The
cytolytic agent in BFF was PLO, because a specific anti-PLO
antibody abrogated the cytolytic activity of BFF, and a plo-
deletion mutant of T. pyogenes had no cytolytic activity.
Endometrial stromal cells were markedly more sensitive than
epithelial cells to PLO-mediated cytolysis, and stromal cells
were also more sensitive to PLO than hematopoietic immune
cells or PBMCs. The stromal cell sensitivity to PLO may be
due to these cells containing more cholesterol than epithelial
cells, and reducing cellular cholesterol using cyclodextrins
protected the stromal cells against PLO-mediated cytolysis.
Surprisingly, the endometrial tissue or cells, hematopoietic
immune cells, or PBMCs did not mount detectable inflamma-
tory responses to PLO, although they responded to bacteria by
secreting cytokines and chemokines. In summary, stromal cell
sensitivity to PLO explains how T. pyogenes causes endome-
trial pathology once the protective epithelium is lost after
parturition to exposure the underlying stroma.
T. pyogenes commonly causes severe uterine disease in
postpartum dairy cattle, with tissue damage and inflammation
of the endometrium [2, 5, 8, 9]. In one study, T. pyogenes was
isolated from 42% of swabs collected from the endometrium of
dairy cows 1–4 wk postpartum, and was significantly
associated with uterine disease [36]. Similarly, in the present
study, T. pyogenes acted as a primary pathogen and caused
clinical endometritis with the discharge of pus when bacteria
were infused into the uteri of dairy cows. However, most
uterine infections involve multiple bacteria, both culturable and
nonculturable [2, 37]. In one field study, only 30% of uterine
lavage samples from animals with postpartum metritis yielded
DNA attributable to the presence of T. pyogenes, and 21% of
animals without signs of metritis possessed DNA from the
bacterium [38]. In another study by the same group, T.
pyogenes DNA was not identified from uterine flushings
collected from postpartum cattle, with or without metritis [37].
Interactions between multiple species of bacteria are likely
important in the pathogenesis of clinical disease of the uterus
[2, 37]. However, the present study focused on the mechanisms
linking T. pyogenes to disease in the endometrium, because
isolation of the bacterium is correlated with the amount of pus
in the female genital tract, and with the severity of
inflammation in the stromal compartment of the endometrium
[5, 36].
FIG. 5. Kinetics of endometrial cytolysis by PLO. Representative confocal microscope images of three independent experiments using stromal (A) and
epithelial (B) cells treated with Hoechst 33342 (red nuclei) and fluorescently labeled phalloidin (white actin), in control culture medium or medium
containing 30 HU PLO for the indicated times; bar¼ 50 lm. Stromal (C) and epithelial (D) cell florescence intensity measured by confocal microscopy
every 3 min in arbitrary units. Data are presented as mean (SEM) of three independent experiments.
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The secreted pore-forming toxin PLO is considered the
primary virulence factor of T. pyogenes [9], and the plo gene
was expressed by all 57 isolates of T. pyogenes in a survey of
postpartum uterine disease [19]. In the present study, the plo
gene sequence was identical, and the plo gene promoter
sequence was highly conserved among 12 clinical isolates
collected from different farms and countries. The BFF from
each of the isolates caused hemolysis, and caused cytolysis of
endometrial and hematopoietic cells. There was some variation
in the hemolytic activity of the BFF among the T. pyogenes
isolates, which might relate to minor nucleotide variations in
the plo gene promoter. However, this variation in hemolysis
from bacteria grown in vitro may not reflect pathogenicity in
vivo. Moreover, the endometrial cytolytic potency of BFF from
these isolates did not differ significantly when the BFF were
normalized to the same HUs of toxin. As well as finding PLO
protein in BFF, PLO was essential for cytolysis, because a
specific antibody against PLO blocked the hemolytic and
endometrial cytolytic activity of BFF. Furthermore, deletion of
plo prevented hemolysis and abrogated endometrial cytolysis
FIG. 6. Cellular cholesterol concentration and PLO-mediated cytolysis of endometrial cells. A) The cellular cholesterol concentration of 105 stromal and
epithelial cells was determined by cholesterol assay. Data are presented as mean (SEM) of three independent experiments. Significant differences were
determined by independent t-test; *P , 0.05. B) Stromal cells were treated for 0 and 24 h with a-, methyl-b-cyclodextrin or c-cyclodextrin (CD) before
measuring cellular cholesterol concentration. Data are presented as mean (SEM) of three independent experiments. Significant differences were
determined by independent t-test; *P , 0.05. C) Stromal cells were treated with control culture medium (C) or medium containing the indicated
concentrations of a-cyclodextrin, methyl-b-cyclodextrin, or c-cyclodextrin for 24 h before treatment with control culture medium () or medium
containing 15 HU rPLO (þ) for 24 h, and cell survival was monitored by MTT assay. Data are expressed as a percent of control, and are presented as mean
(SEM) of four independent experiments. Significant differences from cells in PLO were determined by ANOVA and Dunnett pairwise t-test; *P , 0.05.
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by live T. pyogenes. In a mouse peritonitis model, PLO was
also important for T. pyogenes virulence [12], and, in other
species of bacteria, mutation of genes in bacteria that encode
CDCs also reduced their virulence [39, 40].
The most striking observation in the present study was the
difference in sensitivity among host cells to PLO. The BFF
from each of the 12 isolates of T. pyogenes consistently caused
more stromal then epithelial cytolysis. Furthermore, endome-
trial stromal cells were markedly more sensitive to rPLO-
mediated cytolysis than epithelial cells, monocytes, neutro-
phils, or lymphocytes. More detail about the kinetics of PLO
action on endometrial cells was obtained using confocal
microscopy to monitor fluorescence of phalloidin bound to
F-actin following pore formation in plasma membranes [30].
More stromal than epithelial cells fluoresced, and the rate of
permeation of stromal cells was more rapid than for epithelial
cells. Therefore, we suggest that, once the endometrial
epithelium is disrupted, PLO-mediated stromal cytolysis is a
key step in the pathogenesis of postpartum endometritis.
The sensitivity of stromal cells and/or the resistance of
epithelial cells to PLO-mediated cytolysis have biological
relevance, because the columnar epithelium of the endometri-
um forms a physical barrier between the uterine lumen and the
underlying stroma. However, after parturition, the epithelial
layer is disrupted and invading microbes access the underlying
stroma [1, 3–5]. The epithelium is disrupted by trauma during
parturition and sloughing of the surface of the uterine caruncles
about 12–14 days postpartum [3, 4]. These events are followed
by cell proliferation and regeneration of the epithelium, which
is completed between 20 and 30 days after parturition [3, 4].
Interestingly, the highest concentrations of T. pyogenes in the
endometrium are detectable during the second and third week
postpartum, prior to regeneration of the epithelium [41]. Once
the stroma is colonized with bacteria, T. pyogenes infection and
endometritis appear to persist [2, 5]; indeed, the tissue damage
associated with infection may delay the re-epithelialization of
the endometrium and foster a chronic infection. However,
compartmentalization by an intact endometrial epithelium,
mucus, and antimicrobial peptides likely prevents new
infections of the endometrium by T. pyogenes beyond 20 days
postpartum. Indeed, mechanical disruption of the endometrial
epithelium of late-lactation dairy cows is important to be able
to generate endometritis in the bovine T. pyogenes challenge
model, as used in the present study [26]. The ability of T.
pyogenes to cause pathology in the denuded endometrium is
similar to the discovery of endometrial pathogenic E. coli that
is adapted to the bovine endometrium [6]. On the other hand,
the resistance of epithelial cells to PLO is also an example of
how basal tolerance against a microbe can be used as an innate
defense strategy in animals [13].
Most members of the family of CDCs bind cholesterol in
host cell plasma membranes and then oligomerize to form a
pore [9, 10]. CDCs, including PLO, can even bind and form
pore-like structures on cholesterol crystals in a cell-free system
FIG. 7. Endometrial tissue responses to T. pyogenes and PLO. In vitro organ cultures of endometrium were treated for 24 h with control culture medium
or medium containing 103–107 live T. pyogenes (A), 103–107 live T. pyogenes Dplo (B), or 0.003–30 HU rPLO (C), with culture medium containing 1 lg/
ml LPS used as a positive control in each case. Concentrations of IL-1b, IL-6, and IL-8 in supernatants were measured by ELISA. Data were normalized to
the weight of each tissue in culture, and presented as mean (SEM) pg/mg tissue from four independent experiments. Significant differences from control
were determined by ANOVA and Dunnett pairwise t-test; *P , 0.05. ND, values below the limits of detection.
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[11]. However, ring-shaped cyclodextrins, particularly methyl-
b-cyclodextrin, bind and sequester cholesterol molecules [31].
Furthermore, because CDCs target cholesterol, the removal of
cholesterol from cell membranes using cyclodextrins can
reduce the hemolytic activity of CDCs [10]. In the present
study, it was notable that stromal cells had higher cellular
cholesterol content, and they were more sensitive to PLO-
mediated cytolysis than epithelial cells. Furthermore, treating
endometrial stromal cells with methyl-b-cyclodextrin also
efficiently reduced cellular cholesterol content to a similar
concentration found in epithelial cells. More importantly,
addition of methyl-b-cyclodextrin protected the stromal cells
against PLO-mediated lysis. As tissue damage is an important
feature of uterine disease, reducing cytolysis using methyl-b-
cyclodextrin might reduce the impact of T. pyogenes.
In addition to tissue damage, postpartum bacterial infection
of the endometrium is also characterized by inflammation [7,
17]. Many highly conserved microbial molecules act as
PAMPs that bind host cell pattern recognition receptors to
stimulate inflammation [14]. Similarly, in the present study, T.
pyogenes stimulated in vitro organ cultures of endometrium or
endometrial cells to secrete inflammatory mediators indicative
of an innate immune response. The response to T. pyogenes is
readily explained by the presence of many common PAMPs in
whole bacteria, such as lipopeptides and nucleic acids [14]. In
addition, we also considered if PLO might be a PAMP, because
other CDCs are thought to provoke an innate immune response
[15, 16, 35]. However, in the present study, endometrial tissue,
stromal or epithelial cells, or hematopoietic immune cells did
not produce detectable amounts of cytokines or chemokines in
response to PLO. The cells were capable of mounting
FIG. 8. Host cell inflammatory responses to T. pyogenes and PLO. Pure populations of primary bovine endometrial stromal and epithelial cells were
treated for 24 h with 0.1–1000 MOI heat-killed T. pyogenes (HKTP; A) or 0.003–30 HU rPLO (B), with culture medium as a control, and 1 lg/ml LPS as a
positive control. The concentrations of IL-6 and IL-8 that accumulated in the supernatant were measured by ELISA. Data are presented as mean (SEM) of
four independent experiments. Significant differences were determined by ANOVA and Dunnett two-sided post hoc comparison with control; *P , 0.05.
ND, values below the limits of detection.
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inflammatory responses as the prototypical PAMP LPS
simulated the release of cytokines and chemokines, as expected
from previous observations of bovine endometrial cells [17].
Furthermore, the use of a prototypical CDC, SLO, did not
provoke inflammatory responses by endometrial cells in the
present study.
Taken together, the data from the present study indicate that
T. pyogenes bacteria provoke a cellular inflammatory response,
whereas PLO causes cytolysis. Conversely, the plo-deletion
mutants of T. pyogenes do not appear to cause cytolysis, and
rPLO did not stimulate the release of cytokines or chemokines.
Of course, during clinical infections in the whole animal, T.
pyogenes cause tissue damage and inflammation of the
endometrium, often in association with other species of
bacteria [2, 5, 8, 36]. These bacteria posses a range of PAMPs,
including bacterial lipopeptides, nucleic acids, and LPS. The
multiple PAMPs stimulate inflammatory responses by hema-
topoietic cells and by endometrial cells [14, 42]. In particular,
endometrial epithelial and stromal cells mount inflammatory
responses to LPS via Toll-like receptor (TLR) 4, and to
bacterial lipopeptides via heterodimers of TLR2 with TLR1 or
TLR6 [17, 43]. Although most PAMPs are highly conserved
molecules from prokaryotes, it appears from our work that,
while PLO is highly conserved, it is not a potent PAMP. In
vivo, the presence of tissue damage caused by microbial
virulence factors is also thought to increase the scale of the
inflammatory response to bacterial infection beyond that
attributable to the presence of PAMPs [44]. The release of
damage-associated molecular patterns (DAMPs) from dying
cells and damaged tissues are thought to stimulate inflamma-
tion when DAMPs are bound by pattern recognition receptors,
including TLRs [45, 46]. However, the lack of inflammatory
responses to cytolysis caused by PLO in the present study
somewhat counters this concept of DAMPs stimulating
inflammation. Although DAMPs were not specifically mea-
sured in the present study, PLO treatment caused cytolysis of
all the types of cells examined, and yet no increase in the
concentrations of inflammatory mediators was evident in cell
or tissue culture supernatants. Further investigation of the
DAMPs released when cells are exposed to CDCs, and
examination of other types of cellular responses to CDCs, is
warranted. Indeed, an insight into the latter was evident in the
present study, because sublytic concentrations of PLO
stimulated stromal cell proliferation. Similar results have been
reported with Staphylococcus a-toxin, where transiently
permeated keratinocytes were found to proliferate via an
epidermal growth factor receptor-dependent pathway [47]. In
the absence of inflammatory mediator responses to pore-
forming toxins, cellular proliferation may be an example of an
induced resistance mechanism to limit the impact of tissue
damage in animals [13].
In conclusion, the marked sensitivity of stromal cells to
PLO-mediated cytolysis provides an explanation for how T.
pyogenes acts as an opportunistic pathogen to cause pathology
of the endometrium once the protective epithelium is lost after
parturition.
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SUPPLEMENTAL FIGURE LEGENDS 
Supplemental Figure S1. Comparison of the plo gene. The DNA sequence coding for plo was obtained 
for 12 clinical isolates of T. pyogenes isolates and collected from the NCBI database (Genbank 
accessions: AAC45754, ADU04496, BAA86937), along with Arcanobacterium hemolyticum DSM 20595 
thiol-activated cytolysin sequence (YP_003697395) and the Streptococcus suis thiol-activated cytolysin 
sequence YP_006358469).  Sequences were used in phylogeny.fr webserver to present the data as a 
phylogenetic tree (Dereeper et al 2008 [27]). 
Reference 
27. Dereeper A, Guignon V, Blanc G, Audic S, Buffet S, Chevenet F, Dufayard JF, Guindon S, Lefort V, 
Lescot M, Claverie JM, Gascuel O. Phylogeny.fr: robust phylogenetic analysis for the non-specialist. 
Nucleic Acids Res  2008; 36:W465-469. 
 
Supplemental Figure S2.  Comparison of the plo promoter region. The plo gene promoter region from 
12 clinical Trueperella pyogenes isolates was sequenced. The promoter region of isolates MS249, 
MS295, MS340 and MS348 were identical and used to comprise a consensus sequence, which was highly 
similar a sequence published previously (Rudnick et al, 2008 [48]).  The colored bases correspond to the 
base in the sequence of isolates of that color (shown in the key) which varies from the consensus 
sequence. The regions described by Rudnick et al (2008 [48]) as direct repeats DR1, DR2 and DR3 are 
identical; in both the regions described as promoters P1 and P2 there was a transposition in nucleotides 1 
and 2.   
Reference 
48. Rudnick ST, Jost BH, Billington SJ. Transcriptional regulation of pyolysin production in the animal 
pathogen, Arcanobacterium pyogenes. Vet Micro, 2008; 132:96-104. 
 
Supplemental Figure S3.  Characteristics of Trueperella pyogenes. (A) Bacterial growth curves were 
generated for each of 12 T. pyogenes clinical isolates as determined by measuring OD600 by 
spectrophotometer every 2 h for 24 h. Data are presented as mean (SEM) of 3 replicates for each isolate. 
(B) Hemolytic activity was measured for bacterial free filtrates (BFF) collected from each isolate at each 
indicated time point during growth. Data are presented as mean (SEM) of 3 BFF for each isolate. (C) 
Hemolytic activity in hemolytic units (HU) of bacteria-free filtrate (BFF) collected after 16 h growth of 
each of 12 T. pyogenes clinical isolates. Data are presented as mean (SEM) of 3 replicates for each 
isolate. (D) Pyolysin (PLO) protein was detected in BFF collected after 8, 16, 20 and 24 h bacterial 
growth. The BFF were dialyzed and concentrated, prior to SDS PAGE and Western blot using αPLO goat 
serum. Typical images are shown for isolate MS249. 
 
Supplemental Figure S4. Endometrial cell survival after treatment with T. pyogenes ∆plo.  Cell survival 
was calculated from MTT assays of (A) stromal and (B) epithelial cells after treatment with 1 to 100 
multiplicities of infection (MOI) live T. pyogenes ∆plo for 24 h.  Data presented as mean (SEM) of 4 
independent experiments. Values did not differ from control following ANOVA. 
 
Supplemental Figure S5. Peripheral blood mononuclear cell responses to pyolysin.  (A)  Peripheral 
blood mononuclear cells were isolated and treated with control culture medium, or medium containing 
0.003 to 3 HU recombinant pyolysin (rPLO), or culture medium containing 1 µg/ml ultrapure 
lipopolysaccharide (LPS) as a positive control.  The concentrations of IL-1β, IL-6, and IL-8 in 
supernatants were measured by ELISA.  (B) Cell survival was evaluated by MTT assay and expressed as 
a percentage of cells in control culture medium. Data presented as mean (SEM) of 4 independent 
experiments.  Values differ from control following ANOVA and Dunnett’s’s two sided comparison 
against control, * P < 0.05 
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SUPPLEMENTAL TABLE S1 
 
Supplemental Table S1.  Primer sequences and restriction enzyme sites used in plo  mutagenesis. 
Oligonucleotide primer sequence 
(restriction site underlined) 
Restriction site  
KanRF:  GTGAATTCTACACATCTCAACCAT EcoRI 
KanRR:  CCAGAATTCCAACCAATTAACCAA EcoRI 
PloUF:   GTGTCGACCCTCCTGTTCAG SalI 
PloUR:  GCCGAATTCAGGTCAACTTTATC EcoRI 
PloDF:  AAGGAATTCCGTACACCCAAG EcoRI 
PloDR:  TCGTCTAGATACGCAGAATCATGAG XbaI 
 
  
 
BOR-Papers in Press. Published as DOI: 10.1095/biolreprod.113.115972
Copyright 2014 by The Society for the Study of Reproduction.
